| Literature DB >> 12842902 |
Robert Rauchenberger1, Eric Borges, Elisabeth Thomassen-Wolf, Eran Rom, Rivka Adar, Yael Yaniv, Michael Malka, Irina Chumakov, Sarit Kotzer, Dalia Resnitzky, Achim Knappik, Silke Reiffert, Josef Prassler, Karin Jury, Dirk Waldherr, Susanne Bauer, Titus Kretzschmar, Avner Yayon, Christine Rothe.
Abstract
The human combinatorial antibody library Fab 1 (HuCAL-Fab 1) was generated by transferring the heavy and light chain variable regions from the previously constructed single-chain Fv library (Knappik, A., Ge, L., Honegger, A., Pack, P., Fischer, M., Wellnhofer, G., Hoess, A., Wölle, J., Plückthun, A., and Virnekäs, B. (2000) J. Mol. Biol. 296, 57-86), diversified in both complementarity-determining regions 3 into a novel Fab display vector, yielding 2.1 x 10(10) different antibody fragments. The modularity has been retained in the Fab display and screening plasmids, ensuring rapid conversion into various antibody formats as well as antibody optimization using prebuilt maturation cassettes. HuCAL-Fab 1 was challenged against the human fibroblast growth factor receptor 3, a potential therapeutic antibody target, against which, to the best of our knowledge, no functional antibodies could be generated so far. A unique screening mode was designed utilizing recombinant functional proteins and cell lines differentially expressing fibroblast growth factor receptor isoforms diversified in expression and receptor dependence. Specific Fab fragments with subnanomolar affinities were isolated by selection without any maturation steps as determined by fluorescence flow cytometry. Some of the selected Fab fragments completely inhibit target-mediated cell proliferation, rendering them the first monoclonal antibodies against fibroblast growth factor receptors having significant function blocking activity. This study validates HuCAL-Fab 1 as a valuable source for the generation of target-specific antibodies for therapeutic applications.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12842902 DOI: 10.1074/jbc.M303164200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157